Bora Pharmaceuticals Co., Ltd. has released its financial results for the first quarter of 2026, reporting an earnings per share (EPS) of NT$0.21, operating revenue of NT$4.001 billion, and net profit after tax of NT$0.32 billion. These figures highlight the company's financial performance within the biotechnology and medical industry.
Company Code: 6472
Company Name: Bora Pharmaceuticals Co., Ltd.
Industry: Biotechnology and Medical Industry
Fiscal Period: Q1 2026
Basic Earnings Per Share (EPS): NT$0.21
Operating Revenue: NT$4.001 billion
Net Profit After Tax: NT$0.32 billion
FACT BOX
- Source: PR Times
- Category: Survey